Prevention of polymorphonuclear leukocyte agglutination in vitro.
Schinella
M
M
Kojikara
P
P
Curci
V
V
D000328:Adult; D016477:Artifacts; D001800:Blood Specimen Collection / Q000379:methods*; D002449:Cell Aggregation / Q000187:drug effects; D002951:Citrates / Q000494:pharmacology*; D019343:Citric Acid; D004338:Drug Combinations; D004492:Edetic Acid / Q000494:pharmacology; D005947:Glucose / Q000031:analogs & derivatives / Q000494:pharmacology; D006801:Humans; D007958:Leukocyte Count; D007970:Leukopenia / Q000097:blood / Q000139:chemically induced / Q000175:diagnosis*; D008297:Male; D009504:Neutrophils / Q000187:drug effects*; D010634:Phenobarbital / Q000009:adverse effects; D011732:Pyridoxal Phosphate / Q000494:pharmacology*; D014325:Tromethamine / Q000494:pharmacology*; D014635:Valproic Acid / Q000009:adverse effects
D002951:Citrates; D004338:Drug Combinations; C064185:pyridoxal phosphate, trisodium citrate, tromethamine drug combination; D014325:Tromethamine; C002113:acid citrate dextrose; D019343:Citric Acid; D011732:Pyridoxal Phosphate; D014635:Valproic Acid; D004492:Edetic Acid; D005947:Glucose; D010634:Phenobarbital